<SEC-DOCUMENT>0001437749-20-000060-index.html : 20200102
<SEC-HEADER>0001437749-20-000060.hdr.sgml : 20200102
<ACCEPTANCE-DATETIME>20200102160400
ACCESSION NUMBER:		0001437749-20-000060
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20191226
ITEM INFORMATION:		Cost Associated with Exit or Disposal Activities
ITEM INFORMATION:		Changes in Registrant's Certifying Accountant
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200102
DATE AS OF CHANGE:		20200102

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vaxart, Inc.
		CENTRAL INDEX KEY:			0000072444
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				591212264
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35285
		FILM NUMBER:		20501516

	BUSINESS ADDRESS:	
		STREET 1:		290 UTAH AVE., SUITE 200
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 550-3500

	MAIL ADDRESS:	
		STREET 1:		290 UTAH AVE., SUITE 200
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Aviragen Therapeutics, Inc.
		DATE OF NAME CHANGE:	20160413

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Biota Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20121113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NABI BIOPHARMACEUTICALS
		DATE OF NAME CHANGE:	20100719
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>vxrt20200102_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
Document 1 - file: vxrt20200102_8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-16.1
<SEQUENCE>2
<FILENAME>ex_168498.htm
<DESCRIPTION>EXHIBIT 16.1
<TEXT>
Document 2 - file: ex_168498.htm

</DOCUMENT>
</SEC-DOCUMENT>